What is Artiva Biotherapeutics, Inc. Common Stock's Market Cap?

Artiva Biotherapeutics, Inc. Common Stock's Market Cap is $300.7M, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Enterprise Value?

Artiva Biotherapeutics, Inc. Common Stock's Enterprise Value is -$48.7M, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's EV / EBITDA?

Artiva Biotherapeutics, Inc. Common Stock's EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Revenue (TTM)?

Artiva Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Net Income (TTM)?

Artiva Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$90.8M, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's EBITDA?

Artiva Biotherapeutics, Inc. Common Stock's EBITDA is -$93.5M, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Artiva Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.86, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Net Debt?

Artiva Biotherapeutics, Inc. Common Stock's Net Debt is -$349.4M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Artiva Biotherapeutics, Inc. Common Stock

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00VPZJ0G8

6.15▼ 0.05 (-0.81%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 6.20
Day's Range: 5.95 – 6.17
52-Week Range: 2.96 – 14.57
Volume: 313.7K
Avg Volume: 502.3K

Share Statistics

Shares Outstanding
Employees: 104
Exchange: XNAS
Listed: 2024-07-19

Share count as of July 31, 2026

Artiva Biotherapeutics, Inc. Common Stock (ARTV) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Artiva Biotherapeutics, Inc. Common Stock (ARTV)

What is Artiva Biotherapeutics, Inc. Common Stock's Market Cap?: Artiva Biotherapeutics, Inc. Common Stock's Market Cap is $300.7M, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Enterprise Value?: Artiva Biotherapeutics, Inc. Common Stock's Enterprise Value is -$48.7M, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's EV / EBITDA?: Artiva Biotherapeutics, Inc. Common Stock's EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Revenue (TTM)?: Artiva Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Net Income (TTM)?: Artiva Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$90.8M, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's EBITDA?: Artiva Biotherapeutics, Inc. Common Stock's EBITDA is -$93.5M, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Artiva Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.86, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Net Debt?: Artiva Biotherapeutics, Inc. Common Stock's Net Debt is -$349.4M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · ARTVAs-filed SEC (XBRL) data